| | 815610-63-0 Basic information More.. |
| Product Name: | Ustekinumab | | Synonyms: | ustekinumab;Ustekinumab USP/EP/BP;Research Grade Ustekinumab(DHD84001);inhibit,Interleukin Related,Inhibitor,Ustekinumab | | CAS: | 815610-63-0 | | MF: | | | MW: | 0 | | EINECS: | | | Mol File: | Mol File |  |
Use
Ustekinumab is the latest biologic to be approved for the treatment of plaque psoriasis. It is a human IgG1k monoclonal antibody that binds with high affinity and specificity to the p40 protein subunit used by both the interleukin-12 (IL-12) and interleukin-23 (IL-23) cytokines. IL-12 and IL-23 are naturally occurring cytokines that are involved in inflammatory and immune responses, such as NK cell activation and CD4+ T-cell differentiation and activation.
- Ustekinumab USP/EP/BP
-
- US $1.10 / g
- 2021-07-02
- CAS:815610-63-0
- Min. Order: 1g
- Purity: 99.9%
- Supply Ability: 100 Tons Min
- Ustekinumab
-
- US $0.00-0.00 / Kg
- 2020-05-03
- CAS:815610-63-0
- Min. Order: 1KG
- Purity: 99.0%
- Supply Ability: 800 ton
|
|
815610-63-0
Recommend Suppliers |
|